Linked Life Data

3191761

Source:http://linkedlifedata.com/resource/pubmed/id/3191761

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3191761rdf:typepubmed:Citationlld:pubmed
pubmed-article:3191761lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C0701159lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C0004096lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C1705822lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C0993596lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C0027524lld:lifeskim
pubmed-article:3191761lifeskim:mentionsumls-concept:C1875297lld:lifeskim
pubmed-article:3191761pubmed:issue6lld:pubmed
pubmed-article:3191761pubmed:dateCreated1989-1-12lld:pubmed
pubmed-article:3191761pubmed:abstractTextThe present study was undertaken to determine if beta-agonists delivered by nebulizer provide better clinical responses than MDI therapy in status asthmaticus. We divided 28 hospitalized asthmatic patients into three groups. Group 1 received albuterol by MDI with InspirEase. Group 2 received nebulized albuterol. Group 3 received nebulized metaproterenol. Both nebulizer regimens resulted in significant improvements in both FVC and FEV1 by 30 min after initial hospital beta-agonist treatment. No significant improvement was noted in initial spirometry in the MDI with InspirEase group. In spite of the superiority of nebulizer therapy in the initial phase of hospitalization, the daily rates of spirometric improvement and duration of hospitalization were not significantly different among the three groups. Our results indicate that nebulizer therapy provides superior spirometric improvement in the initial phase of status asthmaticus. However, both MDI and nebulizer regimens provided similar rates of spirometric improvement and duration of hospitalization.lld:pubmed
pubmed-article:3191761pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3191761pubmed:languageenglld:pubmed
pubmed-article:3191761pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3191761pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3191761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3191761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3191761pubmed:statusMEDLINElld:pubmed
pubmed-article:3191761pubmed:monthDeclld:pubmed
pubmed-article:3191761pubmed:issn0012-3692lld:pubmed
pubmed-article:3191761pubmed:authorpubmed-author:GordonRRlld:pubmed
pubmed-article:3191761pubmed:authorpubmed-author:MorleyT FTFlld:pubmed
pubmed-article:3191761pubmed:authorpubmed-author:GiudiceJ CJClld:pubmed
pubmed-article:3191761pubmed:authorpubmed-author:ZappasodiS...lld:pubmed
pubmed-article:3191761pubmed:authorpubmed-author:MarozsanEElld:pubmed
pubmed-article:3191761pubmed:authorpubmed-author:GriesbackRRlld:pubmed
pubmed-article:3191761pubmed:issnTypePrintlld:pubmed
pubmed-article:3191761pubmed:volume94lld:pubmed
pubmed-article:3191761pubmed:ownerNLMlld:pubmed
pubmed-article:3191761pubmed:authorsCompleteYlld:pubmed
pubmed-article:3191761pubmed:pagination1205-10lld:pubmed
pubmed-article:3191761pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:meshHeadingpubmed-meshheading:3191761-...lld:pubmed
pubmed-article:3191761pubmed:year1988lld:pubmed
pubmed-article:3191761pubmed:articleTitleComparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients.lld:pubmed
pubmed-article:3191761pubmed:affiliationDepartment of Medicine, University of Medicine and Dentistry of New Jersey/School of Osteopathic Medicine, Stratford.lld:pubmed
pubmed-article:3191761pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3191761pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3191761pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3191761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3191761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3191761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3191761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3191761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3191761lld:pubmed